Svenningsson, Anna L.
Stomrud, Erik
Insel, Philip S.
Mattsson, Niklas
Palmqvist, Sebastian
Hansson, Oskar
Article History
Received: 19 March 2019
Accepted: 11 July 2019
First Online: 1 August 2019
Competing Interests
: O.H. has acquired research support (for the institution) from Roche, G.E. Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Biogen, Roche, and Fujirebio. A.L.S., E.S., P.S.I., N.M. and S.P. report no disclosures.